Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

MLA

Rasmussen, K., et al. “Electrophysiological Effects of Diphenylpyrazolidinone Cholecystokinin-B and Cholecystokinin-A Antagonists on Midbrain Dopamine Neurons.” The Journal of Pharmacology and Experimental Therapeutics, vol. 264, no. 1, Jan. 1993, pp. 480–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs29443782&authtype=sso&custid=ns315887.

APA

Rasmussen, K., Czachura, J. F., Stockton, M. E., & Howbert, J. J. (1993). Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics, 264(1), 480–488.

Chicago

Rasmussen, K, J F Czachura, M E Stockton, and J J Howbert. 1993. “Electrophysiological Effects of Diphenylpyrazolidinone Cholecystokinin-B and Cholecystokinin-A Antagonists on Midbrain Dopamine Neurons.” The Journal of Pharmacology and Experimental Therapeutics 264 (1): 480–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs29443782&authtype=sso&custid=ns315887.